Abstract
We examine the spread of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Italy, to address the appropriate methodological choices for the design of selective relaxations of the current containment measures. Pressing relevance stems from the need to restart the economy dramatically affected by the lockdown. We employ a spatially explicit, data-intensive model of the patterns of disease spread in Italy, which devotes proper attention to the paramount role of inapparent infections. We aim at providing tools to: estimate the baseline trajectory, i.e. the expected unfolding of the outbreak if the current containment measures were kept in place indefinitely; assess possible deviations from the baseline, should relaxations of the current lockdown result in increased disease transmission; and estimate the isolation effort required to prevent a resurgence of the outbreak. A 40% increase in effective transmission as a result of the loosening of confinement measures would yield an epidemic curve that shows a major rebound, larger than the previous peaks in most regions. A control effort capable of isolating a daily percentage of approximately 5.5 % of the exposed and highly infectious individuals proves necessary to counterbalance such an increase and maintain the epidemic curve onto the decreasing baseline trajectory. We explore several scenarios, provide the basic data to design the related control strategies, and discuss their feasibility. Should suitable control via tracing and testing prove unfeasible, stop-and-go enforcement or delay of the lockdown relaxations would be necessary to reduce the isolation effort required to maintain the epidemic trajectory under control.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
EB, DP and AR acknowledge funding from Fondazione Cassa di Risparmio di Padova e Rovigo (IT) through its grant 55722 (April 2020)
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data used in this manuscript are publicly available. COVID-19 epidemiological data for Italy are available at https://github.com/pcm-dpc/COVID-19. Mobility data at municipality scale are available at https://www.istat.it/it/archivio/139381. Population census data are available at http://dati.istat.it/Index.aspx?QueryId=18460.
https://github.com/pcm-dpc/COVID-19